CNMP EGFR mutado. A favor de no hacer secuenciación

2 / 38

How to choose the best front line therapy
for metastatic EGFR mutant NSCLC
• Therapy most biologically sound
• Targeted therapy with immediate efficacy—both
systemic and CNS
• Therapy with low to modest toxicity profile
• Therapy that will prolong survival
• Impact on subsequent therapy—ultimately, use the
best drug first